Biocon Q1 Results: Profit Slumps 95% Even As Revenue Rises

Biocon Ltd. reported a 95% fall in net profit for the first quarter of financial year 2026.

The pharma company reported a consolidated bottom line of Rs 31.4 crore, a sharp fall from net profit of Rs 659.70 crore in the year-ago period.

• Revenue up 14.8% to Rs 3,941.90 crore versus Rs 3,432.90 crore.

• Net profit down 95% to Rs 31.40 crore versus Rs 659.70 crore.

• Ebitda up 21% to Rs 748.90 crore versus Rs 620.40 crore.

• Margin at 19% versus 18.1%